After finishing at $4.77 in the prior trading day, Tenaya Therapeutics Inc (NASDAQ: TNYA) closed at $4.97, up 4.30%. In other words, the price has increased by $+0.2050 from its previous closing price. On the day, 1109144 shares were traded.
Ratios:
Our goal is to gain a better understanding of TNYA by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.55 and its Current Ratio is at 6.55. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 30, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 05 ’24 when Hoey Timothy sold 3,300 shares for $7.00 per share. The transaction valued at 23,101 led to the insider holds 245,346 shares of the business.
Hoey Timothy sold 6,569 shares of TNYA for $35,046 on Feb 20 ’24. The Chief Scientific Officer now owns 236,146 shares after completing the transaction at $5.34 per share. On Feb 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 6,500 shares for $5.86 each. As a result, the insider received 38,090 and left with 73,534 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 384.23M and an Enterprise Value of 274.52M.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $8.09, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 4.8345, while the 200-Day Moving Average is calculated to be 3.9727.
Shares Statistics:
The stock has traded on average 616.98K shares per day over the past 3-months and 842.4k shares per day over the last 10 days, according to various share statistics. A total of 66.86M shares are outstanding, with a floating share count of 60.72M. Insiders hold about 21.14% of the company’s shares, while institutions hold 46.60% stake in the company. Shares short for TNYA as of Feb 29, 2024 were 2.84M with a Short Ratio of 4.61, compared to 2.68M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.69% and a Short% of Float of 5.13%.
Earnings Estimates
Its stock is currently analyzed by 8 different market analysts. On average, analysts expect EPS of -$0.44 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.5, while EPS last year was -$0.61. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.41 and low estimates of -$0.47.
Analysts are recommending an EPS of between -$1.68 and -$1.8 for the fiscal current year, implying an average EPS of -$1.73. EPS for the following year is -$1.67, with 7 analysts recommending between -$1.1 and -$1.99.
